Eton Pharmaceuticals Inc (ETON) — Capital Reinvestment Ratio
Eton Pharmaceuticals Inc (ETON) has a Capital Reinvestment Ratio of 0.00x as of June 2026, meaning it reinvests 0% of its operating cash flow ($7.25 Million) in capital expenditures ($5.00K). Check Eton Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eton Pharmaceuticals Inc Capital Reinvestment Ratio (2022–2025)
This chart tracks Eton Pharmaceuticals Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Eton Pharmaceuticals Inc.
Annual Capital Reinvestment Ratio for Eton Pharmaceuticals Inc (2022–2025)
Year-by-year Capital Reinvestment Ratio for Eton Pharmaceuticals Inc from 2022 to 2025. See ETON free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $10.52 Million | $333.00K | ▲ +17.9% |
| 2024 | 0.03x | $969.00K | $26.00K | ▼ -76.4% |
| 2023 | 0.11x | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 0.58x | $4.82 Million | $2.79 Million | — |